The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension

Journal of Biological Chemistry

Volumn 290, Issue 4, 2015, Pages 2069-2085

  Bertero, Thomas ^a   Cottrill, Katherine ^a   Krauszman, Adrienn ^b   Lu, Yu ^a   Annis, Sofia ^a   Hale, Andrew ^a   Bhat, Balkrishen ^c   Waxman, Aaron B ^a   Chau, B Nelson ^c   Kuebler, Wolfgang M ^b,d   Chan, Stephen Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c REGULUS THERAPEUTICS   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEX NETWORKS; CROSSTALK; CYTOLOGY; ENDOTHELIAL CELLS; MUSCLE; RNA;

CELLULAR POPULATIONS; COMPLEX DISORDER; GLOBAL REGULATION; PATHOGENIC PATHWAYS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PULMONARY HYPERTENSION; SMOOTH MUSCLE CELLS; VASCULAR CELLS;

CELLS;

MICRORNA; MICRORNA 130; MICRORNA 301; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; ENDOTHELIN; ENDOTHELIN 1; MIRN130 MICRORNA, HUMAN; MIRN301 MICRORNA, HUMAN; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; ALGORITHM; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; HEK293 CELL LINE; METABOLISM; PULMONARY ARTERY; SYSTEMS BIOLOGY; VASCULAR SMOOTH MUSCLE;

ALGORITHMS; ANIMALS; CELLS, CULTURED; ENDOTHELIN-1; ENDOTHELINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; HYPERTENSION, PULMONARY; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDES; PPAR GAMMA; PULMONARY ARTERY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; VASOCONSTRICTION;

EID: 84961292069     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.617845     Document Type: Article

References (50)

1. Schermuly, R. T., Ghofrani, H. A., Wilkins, M. R., and Grimminger, F. (2011) Mechanisms of disease: pulmonary arterial hypertension. Nat. Rev. Cardiol. 8, 443-455
2. Humbert, M., Montani, D., Perros, F., Dorfmüller, P., Adnot, S., and Eddahibi, S. (2008) Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascul. Pharmacol. 49, 113-118
3. Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., and Stewart, D. J. (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328, 1732-1739
4. Wang, L., Yin, J., Nickles, H. T., Ranke, H., Tabuchi, A., Hoffmann, J., Tabeling, C., Barbosa-Sicard, E., Chanson, M., Kwak, B. R., Shin, H. S., Wu, S., Isakson, B. E., Witzenrath, M., de Wit, C., Fleming, I., Kuppe, H., and Kuebler, W. M. (2012) Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction. J. Clin. Invest. 122, 4218-4230
5. Bertero, T., Lu, Y., Annis, S., Hale, A., Bhat, B., Saggar, R., Saggar, R., Wallace, W. D., Ross, D. J., Vargas, S. O., Graham, B. B., Kumar, R., Black, S. M., Fratz, S., Fineman, J. R., West, J. D., Haley, K. J., Waxman, A. B., Chau, B. N., Cottrill, K. A., and Chan, S. Y. (2014) Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. J. Clin. Invest. 124, 3514-3528
6. Chan, S. Y., Zhang, Y. Y., Hemann, C., Mahoney, C. E., Zweier, J. L., and Loscalzo, J. (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 10, 273-284
7. Gou, D., Ramchandran, R., Peng, X., Yao, L., Kang, K., Sarkar, J., Wang, Z., Zhou, G., Zhou, G., and Raj, J. U. (2012) miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. Am. J. Physiol. Lung Cell Mol. Physiol. 303, L682-L691
8. Ciuclan, L., Bonneau, O., Hussey, M., Duggan, N., Holmes, A. M., Good, R., Stringer, R., Jones, P., Morrell, N. W., Jarai, G., Walker, C., Westwick, J., and Thomas, M. (2011) A novel murine model of severe pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 184, 1171-1182
9. Rabinovitch, M. (2010) PPARγ and the pathobiology of pulmonary arterial hypertension. Adv. Exp. Med. Biol. 661, 447-458
10. Alastalo, T. P., Li, M., Perez Vde, J., Pham, D., Sawada, H., Wang, J. K., Koskenvuo, M., Wang, L., Freeman, B. A., Chang, H. Y., and Rabinovitch, M. (2011) Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J. Clin. Invest. 121, 3735-3746
11. Hansmann, G., de Jesus Perez, V. A., Alastalo, T. P., Alvira, C. M., Guignabert, C., Bekker, J. M., Schellong, S., Urashima, T., Wang, L., Morrell, N. W., and Rabinovitch, M. (2008) An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J. Clin. Invest. 118, 1846-1857
12. Guignabert, C., Alvira, C. M., Alastalo, T. P., Sawada, H., Hansmann, G., Zhao, M., Wang, L., El-Bizri, N., and Rabinovitch, M. (2009) Tie2-mediated loss of peroxisome proliferator-activated receptor-γ in mice causes PDGF receptor-β-dependent pulmonary arterial muscularization. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L1082-J1090
13. Kang, B. Y., Kleinhenz, J. M., Murphy, T. C., and Hart, C. M. (2011) The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 301, L881-L891
14. Kang, B. Y., Park, K. K., Green, D. E., Bijli, K. M., Searles, C. D., Sutliff, R. L., and Hart, C. M. (2013) Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature. PLoS One 8, e79503
15. Stewart, D. J., Levy, R. D., Cernacek, P., and Langleben, D. (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann. Intern. Med. 114, 464-469
16. Bando, K., Vijayaraghavan, P., Turrentine, M. W., Sharp, T. G., Ensing, G. J., Sekine, Y., Szekely, L., Morelock, R. J., and Brown, J. W. (1997) Dynamic changes of endothelin-1, nitric oxide, and cyclic GMP in patients with congenital heart disease. Circulation 96, II-346-351
17. Nagendran, J., Sutendra, G., Paterson, I., Champion, H. C., Webster, L., Chiu, B., Haromy, A., Rebeyka, I. M., Ross, D. B., and Michelakis, E. D. (2013) Endothelin axis is upregulated in human and rat right ventricular hypertrophy. Circ. Res. 112, 347-354
18. Markewitz, B. A., Farrukh, I. S., Chen, Y., Li, Y., and Michael, J. R. (2001) Regulation of endothelin-1 synthesis in human pulmonary arterial smooth muscle cells: effects of transforming growth factor-β and hypoxia. Cardiovasc. Res. 49, 200-206
19. Din, S., Sarathchandra, P., Yacoub, M. H., and Chester, A. H. (2009) Interaction between bone morphogenetic proteins and endothelin-1 in human pulmonary artery smooth muscle. Vascul. Pharmacol. 51, 344-349
20. Barabási, A. L., Gulbahce, N., and Loscalzo, J. (2011) Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56-68
21. Friedman, R. C., Farh, K. K., Burge, C. B., and Bartel, D. P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105
22. Matthews, L., Gopinath, G., Gillespie, M., Caudy, M., Croft, D., de Bono, B., Garapati, P., Hemish, J., Hermjakob, H., Jassal, B., Kanapin, A., Lewis, S., Mahajan, S., May, B., Schmidt, E., Vastrik, I., Wu, G., Birney, E., Stein, L., and D'Eustachio, P. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 37, D619-D622
23. Schaefer, C. F., Anthony, K., Krupa, S., Buchoff, J., Day, M., Hannay, T., and Buetow, K. H. (2009) PID: the Pathway Interaction Database. Nucleic Acids Res. 37, D674-D679
24. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., and Hirakawa, M. (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355-D360
25. Mabbott, N. A., Baillie, J. K., Brown, H., Freeman, T. C., and Hume, D. A. (2013) An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics 14, 632
26. Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C. L., Haase, J., Janes, J., Huss, J. W., 3rd, and Su, A. I. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130
27. Parikh, V. N., Jin, R. C., Rabello, S., Gulbahce, N., White, K., Hale, A., Cottrill, K. A., Shaik, R. S., Waxman, A. B., Zhang, Y. Y., Maron, B. A., Hartner, J. C., Fujiwara, Y., Orkin, S. H., Haley, K. J., Laszlo-Barabási, A., Loscalzo, J., and Chan, S. Y. (2012) MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 125, 1520-1532
28. Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., and Sahai, E. (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 9, 1392-1400
29. Sanz-Moreno, V., Gaggioli, C., Yeo, M., Albrengues, J., Wallberg, F., Viros, A., Hooper, S., Mitter, R., Féral, C. C., Cook, M., Larkin, J., Marais, R., Meneguzzi, G., Sahai, E., and Marshall, C. J. (2011) ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell 20, 229-245
30. Kim, J., Kang, Y., Kojima, Y., Lighthouse, J. K., Hu, X., Aldred, M. A., McLean, D. L., Park, H., Comhair, S. A., Greif, D. M., Erzurum, S. C., and Chun, H. J. (2013) An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat. Med. 19, 74-82
31. Rabinovitch, M. (2008) Molecular pathogenesis of pulmonary arterial hypertension. J. Clin. Invest. 118, 2372-2379
32. Rabinovitch, M. (2012) Molecular pathogenesis of pulmonary arterial hypertension. J. Clin. Invest. 122, 4306-4313
33. Hansmann, G., and Zamanian, R. T. (2009) PPARγ activation: a potential treatment for pulmonary hypertension. Sci. Transl. Med. 1, 12ps14
34. Delerive, P., Martin-Nizard, F., Chinetti, G., Trottein, F., Fruchart, J. C., Najib, J., Duriez, P., and Staels, B. (1999) Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ. Res. 85, 394-402
35. Paulin, R., Courboulin, A., Meloche, J., Mainguy, V., Dumas de la Roque, E., Saksouk, N., Côté, J., Provencher, S., Sussman, M. A., and Bonnet, S. (2011) Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation 123, 1205-1215
36. Courboulin, A., Paulin, R., Giguère, N. J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E. R., Biardel, S., Provencher, S., Côté, J., Simard, M. J., and Bonnet, S. (2011) Role for miR-204 in human pulmonary arterial hypertension. J. Exp. Med. 208, 535-548
37. Shimoda, L. A., Sham, J. S., Liu, Q., and Sylvester, J. T. (2002) Acute and chronic hypoxic pulmonary vasoconstriction: a central role for endothe-lin-1? Respir. Physiol. Neurobiol. 132, 93-106
38. Moudgil, R., Michelakis, E. D., and Archer, S. L. (2005) Hypoxic pulmonary vasoconstriction. J. Appl. Physiol. 98, 390-403
39. Vasudevan, S., Tong, Y., and Steitz, J. A. (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934
40. Shimoda, L. A., Sham, J. S., and Sylvester, J. T. (2000) Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol. Res. 49, 549-560
41. Pozeg, Z. I., Michelakis, E. D., McMurtry, M. S., Thébaud, B., Wu, X. C., Dyck, J. R., Hashimoto, K., Wang, S., Moudgil, R., Harry, G., Sultanian, R., Koshal, A., and Archer, S. L. (2003) In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Circulation 107, 2037-2044
42. Liu, Y., Tian, X. Y., Mao, G., Fang, X., Fung, M. L., Shyy, J. Y., Huang, Y., and Wang, N. (2012) Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor. Hypertension 60, 1471-1478
43. Hakim, T. S., Pedoto, A., Mangar, D., and Camporesi, E. M. (2013) Nitric oxide plays a minimal role in hypoxic pulmonary vasoconstriction in isolated rat lungs. Respir. Physiol. Neurobiol. 189, 93-98
44. Sylvester, J. T., Shimoda, L. A., Aaronson, P. I., and Ward, J. P. (2012) Hypoxic pulmonary vasoconstriction. Physiol. Rev. 92, 367-520
45. Chen, Y., and Gorski, D. H. (2008) Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111, 1217-1226
46. Wu, W. H., Hu, C. P., Chen, X. P., Zhang, W. F., Li, X. W., Xiong, X. M., and Li, Y. J. (2011) MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am. J. Hypertens. 24, 1087-1093
47. Meng, S., Cao, J. T., Zhang, B., Zhou, Q., Shen, C. X., and Wang, C. Q. (2012) Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J. Mol. Cell Cardiol. 53, 64-72
48. Wei, C., Henderson, H., Spradley, C., Li, L., Kim, I. K., Kumar, S., Hong, N., Arroliga, A. C., and Gupta, S. (2013) Circulating miRNAs as potential marker for pulmonary hypertension. PLoS One 8, e64396
49. Baggish, A. L., Hale, A., Weiner, R. B., Lewis, G. D., Systrom, D., Wang, F., Wang, T. J., and Chan, S. Y. (2011) Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J. Physiol. 589, 3983-3994
50. Nishimura, D. (2001) BioCarta. Biotech Software & Internet Report. 2, 117-120